The first volunteer has been dosed with a COVID-19 vaccine as part of hVIVO’s phase 1 clinical trial of COVI-VAC. Following on from its announcement in July last year, the CRO, part of Open Orphan (LSE: ORPH), has begun its randomised, double-blinded,...
Open Orphan PLC (LSE: ORPH) has recently extended a contract with a top-three global pharma company. Its Venn Life Services subsidiary, operating out of Breda, Netherlands, will provide chemistry, manufacturing, and control consultancy services to support the client’s...
Open Orphan (LSE: ORPH) subsidiary Venn Life Sciences has extended a consulting contract with a global pharma firm to support two vaccine development programmes. Venn’s Breda office in the Netherlands will handle chemistry, manufacturing and control duties for the...
Human challenge study pioneer and AIM darling Open Orphan (LSE:ORPH) is set for a record-breaking 2021. The joint London and Dublin-listed pharma services firm is now profitable for the first time and it generating large amounts of cash. It’s been some...
Open Orphan (LSE:ORPH) has bagged its second major contract with a top-three global pharmaceutical company in as many months. On Monday, the contract research organization services company revealed unveiled a £4 million deal that will see it become the sponsor and...
